• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对卡他莫拉菌和流感嗜血杆菌的截短脂寡糖-外膜蛋白结合疫苗的免疫特性。

Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.

机构信息

Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia; Institute for Glycomics, Griffith University, Gold Coast, Australia; School of Medical Science, Griffith University, Gold Coast, Australia.

Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia; School of Medical Science, Griffith University, Gold Coast, Australia.

出版信息

Vaccine. 2020 Jan 10;38(2):309-317. doi: 10.1016/j.vaccine.2019.10.014. Epub 2019 Oct 23.

DOI:10.1016/j.vaccine.2019.10.014
PMID:31668366
Abstract

Moraxella catarrhalis and nontypeable Haemophilus influenzae are important bacterial causes of otitis media in children and respiratory diseases in adults. Lipooligosaccharide (LOS) from M. catarrhalis and outer membrane protein 26 (OMP26) from NTHi are major surface antigens identified as potential vaccine components against these organisms. We previously constructed M. catarrhalis in which LOS is truncated, but contains a structure common to the three known serotypes of M. catarrhalis. OMP26 is known to enhance clearance of NTHi following vaccination in animal models, so was chosen as the carrier protein. In this study, we conjugated wild-type and truncated M. catarrhalis detoxified-LOS to a recombinant modified OMP26, rOMP26VTAL. Vaccination of mice with these conjugates resulted in a significant increase in anti-LOS and anti-rOMP26VTAL IgG levels. Importantly, mouse antisera showed complement-mediated bactericidal activity against all M. catarrhalis serotype A and B strains and a NTHi strain tested. Serotypes A & B make up more than 90% of isolates. These data suggest that the LOS and OMP based conjugate can be used as vaccine components and require further investigation in animal models.

摘要

卡他莫拉菌和流感嗜血杆菌是非定型株是儿童中耳炎和成人呼吸道疾病的重要细菌病原体。卡他莫拉菌的脂寡糖(LOS)和无定型流感嗜血杆菌的外膜蛋白 26(OMP26)是主要的表面抗原,被认为是针对这些病原体的潜在疫苗成分。我们之前构建了 LOS 截短但含有三种已知卡他莫拉菌血清型共同结构的卡他莫拉菌。OMP26 已知在动物模型中接种后能增强对 NTHi 的清除作用,因此被选为载体蛋白。在这项研究中,我们将野生型和截短的卡他莫拉菌解毒 LOS 与重组改良 OMP26(rOMP26VTAL)缀合。用这些缀合物对小鼠进行免疫接种可显著增加抗 LOS 和抗 rOMP26VTAL IgG 水平。重要的是,小鼠抗血清对所有测试的 A 型和 B 型卡他莫拉菌菌株以及 NTHi 菌株显示出补体介导的杀菌活性。A 型和 B 型占分离株的 90%以上。这些数据表明,基于 LOS 和 OMP 的缀合物可用作疫苗成分,需要在动物模型中进一步研究。

相似文献

1
Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.针对卡他莫拉菌和流感嗜血杆菌的截短脂寡糖-外膜蛋白结合疫苗的免疫特性。
Vaccine. 2020 Jan 10;38(2):309-317. doi: 10.1016/j.vaccine.2019.10.014. Epub 2019 Oct 23.
2
Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.突变脂寡糖结合疫苗对卡他莫拉菌具有广谱有效性。
Vaccine. 2011 Jun 6;29(25):4210-7. doi: 10.1016/j.vaccine.2011.03.102. Epub 2011 Apr 16.
3
Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.基于脂寡糖的卡他莫拉菌C血清型结合疫苗的生物学和免疫学特性
Infect Immun. 2007 Jun;75(6):2974-80. doi: 10.1128/IAI.01915-06. Epub 2007 Mar 19.
4
Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.用与蛋白质偶联的卡他莫拉菌解毒脂寡糖免疫增强小鼠肺部细菌清除率。
Infect Immun. 2000 Sep;68(9):4980-5. doi: 10.1128/IAI.68.9.4980-4985.2000.
5
Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.基于脂寡糖的缀合物作为卡他莫拉菌(布兰汉菌)疫苗候选物的合成与表征
Infect Immun. 1998 May;66(5):1891-7. doi: 10.1128/IAI.66.5.1891-1897.1998.
6
Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.用来自不可分型流感嗜血杆菌的基于脂寡糖的结合疫苗进行鼻内免疫可增强小鼠鼻咽部的细菌清除能力。
FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):1-10. doi: 10.1111/j.1574-695X.2003.tb00642.x.
7
Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.基于脂寡糖的卡他莫拉菌B血清型缀合疫苗的合成与表征
Infect Immun. 2005 May;73(5):2790-6. doi: 10.1128/IAI.73.5.2790-2796.2005.
8
Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.开发不可分型流感嗜血杆菌脂寡糖的肽模拟表位作为候选疫苗。
J Immunol. 2003 Apr 15;170(8):4373-9. doi: 10.4049/jimmunol.170.8.4373.
9
Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae.外膜蛋白作为不可分型流感嗜血杆菌解毒脂寡糖结合疫苗的载体
Infect Immun. 1999 Oct;67(10):5508-13. doi: 10.1128/IAI.67.10.5508-5513.1999.
10
Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.卡他莫拉菌外膜蛋白CD和UspA作为基于脂寡糖的缀合物新载体的探索。
FEMS Immunol Med Microbiol. 2004 Jun 1;41(2):109-15. doi: 10.1016/j.femsim.2004.02.001.

引用本文的文献

1
Computational identification of membrane proteins for vaccine design against drug-resistant Moraxella catarrhalis.用于设计抗耐药性卡他莫拉菌疫苗的膜蛋白的计算鉴定
Mol Genet Genomics. 2025 Sep 6;300(1):92. doi: 10.1007/s00438-025-02288-w.
2
Otitis media: recent advances in otitis media vaccine development and model systems.中耳炎:中耳炎疫苗研发及模型系统的最新进展
Front Microbiol. 2024 Jan 24;15:1345027. doi: 10.3389/fmicb.2024.1345027. eCollection 2024.
3
Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children.
与非原住民儿童相比,澳大利亚原住民易患中耳炎的儿童产生针对非典型疫苗抗原的高质量血清 IgG,但其滴度较低。
Front Cell Infect Microbiol. 2022 Apr 7;12:767083. doi: 10.3389/fcimb.2022.767083. eCollection 2022.